A Safety, Tolerability and Preliminary Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis (IC) and Hunner's Lesions

Clinical trial NCT01879683 · COMPLETED

Trial details

NCT number: NCT01879683
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Chronic Interstitial Cystitis

Start date: 2013-07-01
Primary completion: 2014-05-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.